Table 4. Changes in body weight and subjective experiences after 12 weeks intervention with TrigozimR (0–1800 mg/d).
| Placebo (n = 22) |
P | TrigozimR (n = 73) |
P | 600 mg (n = 21) |
P | 1200 mg (n = 25) |
P | 1800 mg (n = 27) |
P | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beta | 95%CI | Beta | 95%CI | Beta | 95%CI | Beta | 95%CI | Beta | 95%CI | ||||||
| Weight (kg) | -1.00 | (-2.27,0.27) | 0.105 | -0.71 | (-1.43,0.00) | 0.046 | 0.01 | (-0.96,0.98) | 0.984 | -0.98 | (-2.77,0.82) | 0.264 | -1.14 | (-1.81,-0.46) | 0.001*** |
| Erection (score) | 0.01 | (-0.25,0.27) | 0.948 | 0.07 | (-0.08,0.21) | 0.354 | 0.05 | (-0.20,0.30) | 0.698 | 0.10 | (-0.16,0.36) | 0.430 | 0.05 | (-0.19,0.30) | 0.675 |
| Fitness (score) | -0.01 | (-0.28,0.26) | 0.944 | 0.02 | (-0.13,0.17) | 0.808 | -0.04 | (-0.30,0.23) | 0.782 | 0.04 | (-0.23,0.31) | 0.774 | 0.05 | (-0.21,0.32) | 0.689 |
| Vitality (score) | 0.02 | (-0.24,0.28) | 0.895 | 0.02 | (-0.13,0.16) | 0.817 | 0.02 | (-0.24,0.27) | 0.900 | 0.03 | (-0.23,0.29) | 0.845 | 0.01 | (-0.25,0.27) | 0.935 |
| Sexual desire (score) | 0.04 | (-0.22,0.30) | 0.741 | 0.03 | (-0.11,0.18) | 0.664 | 0.05 | (-0.20,0.30) | 0.686 | 0.01 | (-0.24,0.26) | 0.924 | 0.04 | (-0.22,0.30) | 0.788 |
| Joy having sex (score) | 0.06 | (-0.19,0.31) | 0.655 | 0.02 | (-0.12,0.16) | 0.794 | 0.05 | (-0.20,0.29) | 0.712 | 0.01 | (-0.24,0.26) | 0.916 | 0.00 | (-0.25,0.24) | 0.980 |
Data are beta with 95% confidence intervals and p-values from a Poission mixed model comparing after vs. before intervention within each group. Weight was analysed using a Gaussian mixed model. We observed no interaction effects between group and time.